RecruitingNCT06960798
Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)
Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (Nat-Geno)
Sponsor
University of Oklahoma
Enrollment
150 participants
Start Date
May 2, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to analyze tumor tissue samples from patients of Native American identity with prostate cancer. By examining these samples, researchers hope to understand how different genes in your tumor can influence treatment decisions, how your cancer progresses and the outcome of your cancer.
Eligibility
Sex: MALEMin Age: 18 YearsMax Age: 100 Years
Inclusion Criteria5
- Written informed consent signed and dated by the patient prior to the performance of any study-specific procedures, sampling, or analyses.
- At least 18 years-of-age at the time of signature of the informed consent form (ICF).
- Patients who self-identify as Native American.
- Patients with a pathologically proven diagnosis of PC (any stage).
- Availability of most recent archived tumor samples.
Exclusion Criteria2
- Patients not of Native American descent or identity.
- Patient does not have archival tissue available.
Interventions
OTHERBio-specimen Collection
Tissue samples will be taken from existing archived collections and sent for further analysis.
OTHERBlood Draw
Blood samples will be collected within the first year of enrollment.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06960798
Related Trials
Mechanisms of Resistance to PSMA Radioligand Therapy
NCT054354953 locations
Predictors of Mental Health in Men With Prostate Cancer Undergoing a Patient Empowerment Program
NCT0489583916 locations
64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer
NCT0697084728 locations
INSIGHT-PCa: MRI- and PHI-Guided Risk-Adapted Strategy for Prostate Cancer Diagnosis
NCT073986901 location
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
NCT020646731 location